Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Colonic Neoplasms, Rectal Neoplasms

Rectal Neoplasms

Colonic Neoplasms

Colorectal Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Lymphoma, Large B-Cell, Diffuse

Adenocarcinoma Of Esophagus

Rectal Neoplasms

Stomach Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Small Bowel Adenocarcinoma

Stomach Neoplasms

Locally Advanced Rectal Cancer

Pancreatic Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Chemotherapy Effect

Neoplasms, Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Hepatecellular Carcinoma

Pancreatic Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Biliary Tract Neoplasms Immunotherapy

Colorectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Cholangiocarcinoma

Rectal Neoplasms

Gastrointestinal Neoplasms

Cervical Esophagus Adenocarcinoma

Adenocarcinoma

Stomach Neoplasms

Colonic Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Locally Advanced Rectal Cancer

Colonic Neoplasms

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

SCOTI

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

TRIUNITE-08

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

TRIBE-C

PANCREAS

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

FOBEAR

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

SMART TNT

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

LAP100

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT

PANC

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

CEIL

AIO-KRK-0418

TRIFLUOX-DP

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

AtezoTRIBE2

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

I-FLOAT

Remission

NeoCHIC

BIG

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)

Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)

The Sagittarius Trial